CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways

Yelena Kravtsova-Ivantsiv, Gilad Goldhirsh, Aaron Ciechanover

Open source

DOI
10.1073/pnas.2416909121
Published
2024-12-17
Container
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1073/pnas.2416909121,
  title = {CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways},
  author = {Yelena Kravtsova-Ivantsiv and Gilad Goldhirsh and Aaron Ciechanover},
  year = {2024},
  journal = {Proceedings of the National Academy of Sciences},
  doi = {10.1073/pnas.2416909121},
  url = {https://doi.org/10.1073/pnas.2416909121}
}

RIS

TY  - JOUR
TI  - CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways
AU  - Yelena Kravtsova-Ivantsiv
AU  - Gilad Goldhirsh
AU  - Aaron Ciechanover
PY  - 2024
JO  - Proceedings of the National Academy of Sciences
DO  - 10.1073/pnas.2416909121
UR  - https://doi.org/10.1073/pnas.2416909121
ER  - 

APA

Kravtsova-Ivantsiv, Y., Goldhirsh, G., & Ciechanover, A. (2024). CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2416909121

Source records